Pharmafile - Medical Communications News
The FDA has announced that it had published a list of off-patent, off-exclusivity branded drugs with approved and generics and had also enacted a new...
Sandoz, a division of Swiss pharma giant Novartis, has revealed that two of its biosimilars – Rixathon (biosimilar rituximab) and Erelzi (...
According to the patient records that have been examined so far, at least 1,700 may have been put at risk by the recent blunder that saw NHS...
Featuring an exclusive NHS interview on the recent cyber attack and the full story on the new Brexit Health Alliance, as well as features on patient...
The British Medical Association has revealed that a poll, conducted by British doctors, shows that levels of public dissatisfaction with the NHS is...
The Association of the British Pharmaceutical Industry (ABPI) has announced that it has taken the unusual step of extending the membership suspension...
Pfizer has been dealt a stinging blow by the FDA, after it received a second complete response letter from the Angecy regarding its biosimilar for...
Novartis has revealed that its drug Tafinlar (dabrafenib) has received approval from the FDA for use in combination with Mekinist (trametinib) in...
For the first time in English history, new diagnoses of HIV have fallen across the country – the drop was steepest in areas where HIV testing was...
4.3 million people in the EU are affected by rare cancers, and an estimated 500,000 new cases are diagnosed annually; Dr Terese Johansson highlights...